This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Knc Laboratories Co., Ltd., Kobe University. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 11 
1 out of 143 
Years Active: 2015
Title: Fumi Shima - Innovator in Anticancer Drug Development
Introduction
Fumi Shima is a notable inventor based in Kobe, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer drugs. Her innovative work focuses on compounds that inhibit Ras function, which is crucial in cancer progression.
Latest Patents
Fumi Shima holds a patent for a thioxothiazolidine derivative that exhibits a Ras function inhibitory effect. This invention provides an anticancer drug that effectively inhibits Ras function. The patent describes a Ras function inhibitor comprising a compound represented by a specific formula, or a salt thereof.
Career Highlights
Throughout her career, Fumi Shima has worked with prestigious institutions, including Kobe University and Knc Laboratories Co., Ltd. Her research has been pivotal in advancing the understanding of cancer treatment options.
Collaborations
Fumi has collaborated with several professionals in her field, including Masahiro Neya and Daisuke Sasahara. These collaborations have enriched her research and contributed to her innovative projects.
Conclusion
Fumi Shima's work in developing anticancer drugs showcases her dedication to advancing medical science. Her innovative approach to inhibiting Ras function represents a significant step forward in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile